You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RPRX Conversion Disclosure
Urist Marshall · SEC Form 4 · Filed Nov 6, 2026
Conversion
Calculated transaction value
$0
Urist Marshall EVP, Research & Investments
RPRX
Transaction date
Nov 6, 2026
Public filing date
Nov 6, 2026
Filing lag
Filed same day
RPRX daily price context
Close on/before transaction
$67.3
Nov 6, 2026
First close after public filing
$68.77
Nov 9, 2026
Return after filing · so far
+1.88%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Ordinary Shares
- Quantity / price
- 150,000 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001838139-26-000030
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Royalty Pharma Plc RPRX Current | Conversion | Nov 6, 2026 | $0 |
| Royalty Pharma Plc RPRX | Conversion | Nov 6, 2026 | $0 |
| Royalty Pharma Plc RPRX | Award | Nov 4, 2026 | $0 |